Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, September 30, 2024
SK pharmteco, a global contract development and manufacturing organization (CDMO), announced a major expansion of its small molecule and peptide production capabilities with a $260 million investment to construct a new state-of-the-art facility in ...
read more
Thursday, December 12, 2024
SK pharmteco announced the launch of a brand unification initiative. This strategic move brings together the expertise and capabilities of several industry-respected organizations under the unified SK pharmteco brand.
read more
SK pharmteco has announced a $6.1M investment in its Rancho Cordova, California site to expand and equip a new laboratory and CGMP facility dedicated to kilogram-scale solid-phase peptide synthesis (SPPS) and purification operations.
read more
Wednesday, February 25, 2015
By joining the InCrowd information exchange, Skipta members benefit from personalized access to contribute insights and conveniently complete short, focused research surveys.
read more
Continuum Clinical and Skipta announced the launch of the Center for Observational Research, connecting physicians and available research opportunities within a private and secure digital environment.
read more
Skye Bioscience has entered into an agreement with Novotech Health Holdings (“Novotech”), a leading full-service contract research organization (“CRO”) in Asia-Pacific, for its upcoming Phase 1 study in Australia of its SBI-100 drug candidate for the...
read more
Skyhawk Therapeutics has expanded its strategic collaboration with Merck to discover, develop, and commercialize small molecules that modulate RNA splicing.
read more
Skyland Analytics announced the appointment of James C. Mullen to Skyland's Advisory Board.
read more
Wednesday, November 07, 2018
Skyland Analytics has expanded UK operations with the opening of new offices in Cambridge and London and named Allan Price as Director, European Operations.
read more
Tuesday, January 05, 2021
Slayback Pharma has received final approval for its ANDA for Merzee 1 mg/20 mcg from the FDA with a Competitive Generic Therapy Designation.
read more
The Smart Health Innovation Lab has welcomed OneOme to its 12-week market adoption accelerator program for healthcare technologies.
read more
Tuesday, October 29, 2019
Boston-based Laboratory as a Service (LaaS) company, SmartLabs, announced the expansion of its vivarium program into Kendall Square.
read more
Boston-based Laboratory-as-a-Service (LaaS) leader, SmartLabs, has announced a national expansion with the addition of 80,000 square feet in South San Francisco, California.
read more
SmartLipo365 is voluntarily recalling 122 lots of Smart Lipo (800, 900, 950 mg) capsules, to the consumer level. FDA received samples of 800 and 900mg capsules of Smart Lipo and the lab results found the Smart Lipo products to contain undeclared ...
read more
SMC Ltd announced the acquisition of an end-to-end fill/finish facility in Charlotte, North Carolina. The facility enables SMC to offer a wider portfolio of services to its pharma clients including lab to market development, analytical services, ...
read more